30

Sirio Pharma Co LtdSHE 300791 Stock Report

Last reporting period 30 Sep, 2023

Updated 11 Nov, 2024

Last price

Market cap $B

0.898

Micro

Exchange

XSHE - Shenzhen Stock Exchange

300791.SZ Stock Analysis

30

Neutral

Based on Eyestock quantitative analysis, 300791.SZ`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

53/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

3.0 %

Undervalued

Market cap $B

0.898

Dividend yield

3.11 %

Shares outstanding

180.5 B

Sirio Pharma Co. Ltd. manufactures dietary supplement products. The company is headquartered in Shantou, Guangdong and currently employs 2,456 full-time employees. The company went IPO on 2019-09-25. The firm's main products include soft capsules, tablets, powders, soft candy, hard capsules and oral liquids. The firm's own brand is WEWOW nutritional health food. The firm distributes its products both in the domestic market and to overseas markets.

View Section: Eyestock Rating